A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview. A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview. | | |
|
New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI. New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI. | | |
|
Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective. Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective. | | |
|
|
Interventional cardiology's second Match Day was a significant success. Due to a lack of candidates, however, dozens of fellowship positions remain unfilled. Interventional cardiology's second Match Day was a significant success. Due to a lack of candidates, however, dozens of fellowship positions remain unfilled. | | |
|
According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for younger patients. According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for younger patients. | | |
|
The device, currently just a prototype, could be the first of its kind to gain FDA approval. The device, currently just a prototype, could be the first of its kind to gain FDA approval. | | |
|
|
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call? Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call? | | |
|
According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials. According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials. | | |
|
A clinical trial focused on patients with HFpEF is expected to be completed by July 2026. A clinical trial focused on patients with HFpEF is expected to be completed by July 2026. | | |
|
|
The Health Tech Investment Act would assign all U.S. FDA-cleared AI devices to a new classification under the hospital outpatient payment system. The Health Tech Investment Act would assign all U.S. FDA-cleared AI devices to a new classification under the hospital outpatient payment system. | | |
|
If we would just let it do its thing, AI could fix practically everything that’s wrong with U.S. healthcare. If we would just let it do its thing, AI could fix practically everything that’s wrong with U.S. healthcare. | | |
|
![The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2024-12/screenshot_2024-12-02_at_11.07.21_am.png?itok=hecl3jAc)
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2024-09/istock-1209664264.jpg?itok=d9hdApI9)
